Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ube and Santen patent claims novel agents for glaucoma

Jan. 15, 2008

NicOx and Pfizer extend ophthalmology collaboration agreement

Jan. 10, 2008

E.U. orphan drug status granted for RdCVF for retinitis pigmentosa

Jan. 9, 2008

Allergan patents novel antiglaucoma agents

Jan. 7, 2008

Pfizer initiates Japanese phase II clinical study of PF-03187207 for glaucoma

Jan. 4, 2008

Positive preclinical ocular penetration data reported for topical Zybrestat in ophthalmology

Jan. 3, 2008

Recent Jerini patent discloses novel agents for ocular disorders

Jan. 3, 2008

New site-directed nanoparticle delivery system useful to treat ocular inflammation in vivo

Jan. 3, 2008

ISTA submits NDA to FDA for Xibrom for inflammation, pain and photophobia

Dec. 27, 2007

Novel therapeutic agents for glaucoma reported in recent Allergan patents

Dec. 14, 2007

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...